/C O R R E C T I O N -- Solstice Advanced Materials US, Inc./

Rhea-AI Summary

Solstice Advanced Materials (NASDAQ: SOLS) said its Metropolis Works facility is projected to produce over 10 kilotonnes of UF6 in 2026, about a 20% increase vs planned 2024 capacity. The company cites a backlog of over $2 billion and is exploring further debottlenecking and new capacity investments, supported in part by the U.S. Department of Energy. ConverDyn remains the exclusive marketing agent and the Metropolis license runs through 2060.

Positive

• Projected production >10 kt UF6 in 2026 (~20% expansion vs 2024)
• Backlog of over $2 billion from long-term customers
• Only US UF6 conversion facility (Metropolis Works) with NRC license to 2060
• DOE-supported exploration of additional production and retained EPC firm for expansion

Negative

• None.

Market Reaction

+16.94% $74.61 1.5x vol

15m delay 39 alerts

+16.94% Since News

$74.61 Last Price

$66.11 $75.33 Day Range

+$1.72B Valuation Impact

$11.84B Market Cap

1.5x Rel. Volume

Following this news, SOLS has gained 16.94%, reflecting a significant positive market reaction. Our momentum scanner has triggered 39 alerts so far, indicating elevated trading interest and price volatility. The stock is currently trading at $74.61. This price movement has added approximately $1.72B to the company's valuation. Trading volume is above average at 1.5x the average, suggesting increased trading activity.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Silver for real-time data.

In the news release, Solstice Advanced Materials Announces Expansion of Uranium Conversion Production to Support Strong Nuclear Industry Customer Demand, issued 10-Feb-2026 by Solstice Advanced Materials US, Inc. over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details at the end:

Solstice Advanced Materials Announces Expansion of Uranium Conversion Production to Support Strong Nuclear Industry Customer Demand

Driven by rising demand, expected 2026 production of over 10 kilotonnes of uranium hexafluoride (UF₆) in 2026 would represent an approximate 20% expansion from planned 2024 capacity

Company to explore further debottlenecking at its facility and new capacity investments; current backlog is over $2 billion

MORRIS PLAINS, N.J., Feb. 10, 2026 /PRNewswire/ -- Solstice Advanced Materials, (NASDAQ: SOLS), a global leader in high-performance specialty materials, today announced that its Metropolis Works, Ill., facility is projected to produce over 10 kilotonnes (10 kt) of uranium hexafluoride (UF₆) in 2026, which represents about a 20% increase from its planned output in 2024.

The company has invested in debottlenecking projects at Metropolis Works following its 2023 restart in response to strong customer demand for UF₆, a critical component in the nuclear fuel supply chain. Metropolis Works is the only UF₆ conversion facility in the United States. The company's expansion efforts are underpinned by its backlog of over $2 billion driven by orders from long-term customers, many of which are domestic utility companies, as well as the United States' policy goal of quadrupling American nuclear energy capacity by 2050.

Backed in part by the U.S. Department of Energy (DOE), Solstice is actively exploring additional projects to increase production at its Metropolis Works facility. Solstice has also retained a leading engineering, procurement and construction firm to conduct an initial engineering analysis for new capacity expansion investments and, at the same time, has initiated long-term supply discussions with customers.

"Solstice has stepped up production of UF₆, a critical component in the nuclear fuel supply chain, with the support of disciplined capital investments and improved operational excellence at our Metropolis Works facility," said David Sewell, Solstice President and CEO. "Leveraging our 60-plus years of operational excellence, industry leadership and proprietary expertise, we are exceedingly well-positioned to ensure our capacity to produce converted uranium is aligned with the industry and its rapid expansion."

Solstice's Metropolis Works facility converts uranium ore concentrate from global mines into UF₆ using Solstice's proprietary process, which is recognized for its efficiency and reliability. After Solstice's conversion process, UF₆ is enriched and fabricated by other service providers into nuclear fuel that powers reactors generating nearly 20% of U.S. electricity and representing the largest single source of carbon-free energy in the country, according to the World Nuclear Association.

ConverDyn, a partnership between Solstice and General Atomics, serves as the exclusive marketing agent for all UF₆ produced at the Metropolis Works facility, which holds a license from the U.S. Nuclear Regulatory Commission that is valid until 2060.

About Solstice Advanced Materials
Solstice Advanced Materials is a leading global specialty materials company that advances science for smarter outcomes. Solstice offers high-performance solutions that enable critical industries and applications, including refrigerants, semiconductor manufacturing, data center cooling, nuclear power, protective fibers, healthcare packaging and more. Solstice is recognized for developing next-generation materials through some of the industry's most renowned brands such as Solstice^®, Genetron^®, Aclar^®, Spectra^®, Fluka™ and Hydranal™. Partnering with over 3,000 customers across more than 120 countries and territories and supported by a robust portfolio of over 5,700 patents and pending applications, Solstice's approximately 4,000 employees worldwide drive innovation in materials science.

For more information, visit www.solstice.com.

Forward-Looking Statements
This news release contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the fact that they do not relate strictly to historical or current facts, but rather are based on current expectations, estimates, assumptions and projections. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include, without limitation, ongoing macroeconomic and geopolitical risks, such as changes in or application of trade and tax laws and policies, including the impacts of tariffs and other trade barriers and restrictions, lower GDP growth or recession in the U.S. or globally, supply chain disruptions, capital markets volatility, and inflation, that can affect Solstice's performance in both the near- and long-term. In addition, no assurance can be given that any plan, initiative, projection, goal, commitment, expectation, or prospect set forth in this release can or will be achieved. These forward-looking statements should be considered in light of the information included in this release, Solstice's final information statement, dated October 17, 2025, and other filings with the Securities and Exchange Commission. Any forward-looking plans described herein are not final and may be modified or abandoned at any time. Solstice does not undertake to update or revise any of its forward-looking statements, which speak only as of the date they are made.

Contacts:

Media	Investor Relations
Amy Schneiderman	Mike Leithead
(201) 218-2302	(973) 370-8188
Amy.Schneiderman@teneo.com	Michael.Leithead@solstice.com

CORRECTION: An earlier version of this release included an incorrect hyperlink.

View original content to download multimedia:https://www.prnewswire.com/news-releases/solstice-advanced-materials-announces-expansion-of-uranium-conversion-production-to-support-strong-nuclear-industry-customer-demand-302684108.html

SOURCE Solstice Advanced Materials US, Inc.

FAQ

How much UF6 production does Solstice (SOLS) project for 2026?

Solstice projects production of over 10 kilotonnes of UF6 in 2026, a roughly 20% rise from planned 2024 capacity. According to the company, this follows debottlenecking work at Metropolis Works and reflects strong customer demand and backlog.

What is Solstice's backlog and how does it affect SOLS capacity plans?

Solstice reports a backlog of over $2 billion, which supports expansion planning and capacity investments. According to the company, the backlog is driven by long-term utility orders and underpins further debottlenecking and investment studies.

Is Metropolis Works the only US UF6 conversion facility and how long is its license valid?

Yes — Metropolis Works is the only UF6 conversion facility in the United States and holds an NRC license valid until 2060. According to the company, this long-term license supports sustained domestic conversion capacity.

What steps is Solstice taking to expand UF6 capacity at Metropolis Works?

Solstice is executing debottlenecking projects and has retained an EPC firm for initial engineering on new capacity investments. According to the company, DOE support is involved in evaluating additional production projects.

How does Solstice sell UF6 produced at Metropolis Works (SOLS)?

ConverDyn, a partnership between Solstice and General Atomics, serves as the exclusive marketing agent for UF6 from Metropolis Works. According to the company, ConverDyn handles marketing and sales to utility and other customers.